AT-587 safety study in healthy volunteers
Part of Digestive system, Infections clinical trials.
This trial tests a new medication called AT-587 in healthy people to see if it is safe and how the body processes it. You may help by participating if you are in good health and meet the basic requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old, with a body mass index (BMI) from 18 to 29.
- You must agree to use effective birth control if you or your partner can become pregnant.
- You must have a negative pregnancy test (if female).
- You must not be pregnant or breastfeeding.
- You must not have a history of alcohol or drug abuse.
- You must not have taken any other experimental drugs in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new antibody-based drug in healthy volunteers to see how safe it is and how the body handles it. Participants will receive a single injection and be monitored closely for a few months.
This study tests a new medicine called ATH-097 in healthy people to see how safe it is and how the body handles it. It is a first-in-human study, so participants will receive a single dose and be monitored closely.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This study tests a new medicine called ATI-105 in healthy adults to see if it is safe and how the body handles it. If you are generally healthy, you might be able to participate and help researchers learn more about this potential treatment.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
Hear when a new Hepatitis E trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.